ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)

Running, not enrolling

Conditions studied: Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation

In brief

ASCEND researchers are partnering with families of children who receive extracorporeal membrane oxygenation (ECMO) after a sudden failure of breathing named pediatric acute respiratory distress syndrome (PARDS). ECMO is a life support technology that uses an artificial lung outside of the body to do the lung's work. ASCEND has two objectives. The first objective is to learn more about children's abilities and quality of life among ECMO-supported children in the year after they leave the pediatric intensive care unit. The second objective is to compare short and long-term patient outcomes in two groups of children: one group managed with a mechanical ventilation protocol that reserves the use of extracorporeal membrane oxygenation (ECMO) until protocol failure to another group supported on ECMO per usual care.

Key facts

Study ID
NCT05388708
Run by
University of Michigan
People needed
550
Starts
2021-02-04
Expected to finish
2027-09-30
Last updated by the study team
2026-07-14

Who can join

Age: 0 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.